孤儿药物罕见病用药

5XVNGT*X[M8GXK*OYKGYK*X[Mȍȍ؅ҩओऀ哦ৡ੿ओऀ哦㬮ㅕԨבਸ਼֢छ؟ԗ؆ѫѫմॠ؆ՃઆӐސࠄு୼ࡒ࠙૨ଥ•೑ᆊ亳ક㥃કⲥⴷㅵ⧚ሔᏆण䇗ⱑ㟦䴲ⱘ䖯ষ݀ৌ੠ϔѯए䰶ˈ⬇䇋⡍⅞ϔ⃵ᗻ䖯ষⱑ㟦䴲ˈҹ㾷➗ⳝПᗹDŽ�䞛প᥾ᮑࡴᖿẔ偠ˈࡴᖿᅵᡍ䖯⿟ˈѝপᮽ᮹㾷އⱑ㟦䴲ⷁ㔎ⱘ⢊މDŽ�Ң䖭⃵ⱑ㟦䴲ⱘᮁ䋻ˈࠄℸࠡߎ⦄ⱘ剐㊒㲟ⱑㄝ໮⾡ᄸܓ㥃ⱘⷁ㔎ˈҎӀܙߚ䅸䆚ࠄˈ㽕ֱ䆕ℸ㉏џӊϡݡߎ⦄ˈᖙ乏ሑᖿᓎゟ䍋ℸ㉏㥃કⱘ䭓ᬜկᑨ੠ֱ䱰ᴎࠊˈ⒵䎇ᙷ㗙ⱘЈᑞ⫼㥃䳔∖DŽӊ֨ӹவङઢșО୆ՠगजаङՇ٢ͺșП੽ࢄՃђރ݇كவљՃԛ哦৆ࡺ؆كவثй؅ҩ哦࣒଒੧ӣߤͺșՕਈࢄՃ߄жખङઢொͺș઀ࢵЉї੮Ҹ՛અچͺșރ݇ՕৰͬͬՀৰކࣣՃ଒▲࠵઎ખͺșثйܕճङછџͺݕসșࡒ࠙૨ଥএѐșৡ੿ओऀ哦؅ҩ哦࣒ͧ5XVNGTJX[Mͨङএѐș֢எ࣫ࣙ澝૟Ԏ澝ي߈–؅ҩ哦࣒ङݺঌׂॅ澝ѩۙߚў–ৡ੿ओऀ哦ङ哦࣒৆ࡺ؆ӣߤ–ৡ੿ओऀ哦؅ҩओऀ哦ूՇӣߤ–ࠄ҆ӣߤș؅ҩ哦фսিӣߤͧ:NUSYUT8K[ZKXY/TZKMXOZ_ͨș֢ӄङ࣫ࣙ઎ખՃي߈ࡒ࠙૨ଥЊ۩֢ङՠҁ࢛ଓࡶ୸ș૨ଥ॑ީଉяО࠲֨И֢Է՗߂О㖃С澝ઁࠥ߂О㏎םङ֢எޏ஁ߑߣͬͬਘٶ૜ؼڐ׷ثИ֢଒੧ܕଳͫйٶ֨Їࢁڏॹд௙ЗИ֢ઓৱॻ澞ș䈖ڴԬүࣿͧ*G\OJ)NOVͨйٶੴѠոО૨ଥ॑Ԙчӣ॑॑୸ͫٷۨОٶޏИ֢ۨॹեআ▲ѹࡵ௞И֢ङ૨ଥ॑ઓৱͫ߀ՉӱյیߛۈࣲъӤݎ੿֣ͧ٘ͨ澞șٶͫ䈖ڴԬүࣿՉ଺ӟ٭д૨ଥத֝ЊޏԢପ઒॑ՠҁյٶङங୍঵ھࡴԈ澞6=NU'XK=K%ܼ⧗500ᔎӕϮˈᏖؐ䍙䖛300ғ㕢ܗ᳔໻ⱘᱎ㛑ֵᙃᦤկଚ䞥㵡ǃ⊩ᕟǃ⿢ࡵǃ⾥ᡔǃए⭫عᒋ੠ၦԧ乚ඳⱘϧϮҎ຿DŽ᳡ࡵѢ100໮Ͼ೑ᆊ300໮ϾජᏖ᳡ࡵѢܼ⧗৘乚ඳ14,600legalexperts9,300financialexperts3,000tax&accountingexperts2,600healthcareexperts2,400scientificexperts2,600seasonedjournalists⬅ϧϮҎ຿㓪䕥ЎϧϮҎ຿᳡ࡵNamed#39intheBusinessWeek2011rankingofthe100BestGlobalBrands.ᔎ໻ⱘક⠠∸Ể䏃䗣ᰃܼ⧗乚ܜⱘϧϮϢᱎ㛑ֵᙃᦤկଚࢋՉҒ૓ङ澝ࣞॹङ޴ਈҒێ߆ԇFinancial&RiskIP&ScienceTax&AccountingLegalTradingInvestorsMarketplacesGovernanceRisk&ComplianceLifeSciencesScientific&ScholarlyResearchIntellectualPropertyKnowledgeSolutionsProfessionalCorporateGovernmentLargeLawFirmsGovernmentGeneralCounselsSmallLawFirmsReutersNewsMediaGlobalGrowth&Operations催催䋼䞣ⱘⷨおֵᙃϢᓩ᭛ᴗ࿕ⱘ⾥ⷨ㒽ᬜㅵ⧚Ϣߚᵤ乚ܜⱘ೼㒓ᡩᅵ〓㋏㒳ए㥃ⷨথֵᙃᑇৄ㋏㒳⫳⠽ᄺֵᙃϢ᳡ࡵܼ⧗乚ܜⱘϧ߽ǃᷛޚϢଚֵᷛᙃⶹ䆚ѻᴗⱘ߯䗴ǃㅵ⧚ϢଚϮ࣪ऽજфߓЊॠ܉͹ࢬԋՇ࣫ݐԈӫޏIPSolutionsDISCOVERDEVELOPDELIVERផࡼో⃿ቇᴃ⎇ⓥਈว૞ടㅦ⎇থᓔথਈ೑↪⍮䆚ѻᴗNEWPORTPREMIUM™GENEGOINTEGRITYͽCONSULTINGENDNOTESCHOLARONE㒳㒳㒳㒳CONSULTINGㅵ⧚⧚⧚ϢϢϢଚଚଚଚϮϮϮ࣪࣪࣪DWPI®TechstreetIDRAC®THOMSONINNOVATION®߯ᮄ⫳ੑ਼ᳳIDRAC˄ᬓㄪ⊩㾘˅Newport˄ӓࠊ㥃˅CortellisforCompetitiveIntelligence˄ゟ乍ǃ䗝乍ǃଚϮথሩǃᥜᴗড়԰˅ThomsonReutersIntegrity˄ᮽᳳⷨথ˅Genego˄㋏㒳⫳⠽ᄺ˅ˈMarkush˄࣪ᄺϧ߽˅ࡒ࠙૨ଥॠ܉Њԛऐத֝ͬࣿոॠ؆зЏୂ෎⸔ⷨおЈᑞࠡⷨおI-IIIᳳЈᑞ᡹ᡍথᏗϞᏖӓࠊ㥃㥃⠽থ⦄߆ԇй哦࣒ूՇյߊङЉգஉ࠼ϧֱ߽ᡸ䖛ᳳϧֱ߽ᡸᳳࡒ࠙૨ଥୂӣؚۯ֢ͬஎםֺӲ哦ѣЏՃू९ԥѹࡒ࠙૨ଥୂӣؚۯ֢ͬӄםֺӲ哦ѣЏՃू९ԥѹݕসșৡ੿ओऀ哦؅ҩ哦࣒ͧ5XVNGTJX[Mͨङএѐș֢எ࣫ࣙ澝૟Ԏ澝ي߈–؅ҩ哦࣒ङݺঌׂॅ澝ѩۙߚў–ৡ੿ओऀ哦ङ哦࣒৆ࡺ؆ӣߤ–ৡ੿ओऀ哦؅ҩओऀ哦ूՇӣߤ–ࠄ҆ӣߤș؅ҩ哦фսিӣߤͧ:NUSYUT8K[ZKXY/TZKMXOZ_ͨș֢ӄङ࣫ࣙ઎ખՃي߈ؔУșৡ੿ओ澝؅ҩओ͹ৡ੿ओͧ8GXK*OYKGYKYএ०8*ͨͫЍउԬࣿুৃͧ=.5ͨرҿؔУОےओыރԩۈыՍνङऒओ۪ओՊ澞șऩӹͫٝेઍङৡ੿ओ߄$य़ͫ঳ԩыঝऒओङ澞৲Ќљ࠿ٶ଎य़ङବچଧ׍șИ֢࡚߄ؒސؔУͧےओࣤ͹ͺޏࣿҩےओࣤͨșNZZV]]]INOTGXGXKJOYKGYKIT՟֢؅ҩ哦ॹࡣଋ३1983199020002010㕢೑ᮄࡴവ᮹ᴀ⃻ⲳ▇໻߽Ѯৄ⑒݊Ҫ೑ᆊഄऎDŽDŽDŽܨ߄ৡ੿ओ哦࣒ͧ؅ҩ哦࣒ͨࡣઁङ֢؟ș)GTGJGș6UXZ[MGRș+[XUVKGT;TOUTș'[YZXGROGș9U[ZN1UXKGș4KZNKXRGTJYș/ZGR_ș9]OZ`KXRGTJș8USGTOGș,OTRGTJș3K^OIUș9OTMGVUXKș)NOTGș([RMGXOGș;9'ș/XKRGTJș;TOZKJ1OTMJUSș*KTSGXQș(KRMO[Sș/YXGKRș0GVGTș4UX]G_ș9]KJKTș)`KIN8KV[HROIș-XKKIKș9U[ZN'LXOIGș,XGTIKș'XMKTZOTGș:GO]GTș(XG`ORЉգ֢؟ङઁؔثࡁ㥃џㅵ⧚ˈ2010ˈ7ˈp51ாऩ঍ଣ͹Ӏ߄֌Џ⩽ږԃङঌऋࠄ҆২֢й1983ٶ௃٢ङ߄Ҽৡ੿ओऀ哦ސவङࡣࠄОूՇ؅ҩ哦ङӲ哦ٗЏݕ҈дࢬԋߑӲͺҿѕ֢؟չ֪ԚЭжबݼࡣ澞೼㔩㾕⮙⫼㥃乚ඳЁⱘ㒣⌢⢊ᗕᰃᗢḋⱘ˛䖭ᰃϡᰃϔϾৃҹ㦋߽ⱘⷨথㄪ⬹˛ⷨথⳌ݇ⱘᴎࠊଚϮᏖഎⳌ݇ⱘᴎࠊᄸܓ/㔩㾕⮙ᮍ৥(OrphanDrug/RareDisease)ᄸܓ㥃⠽▔ࢅᴎࠊ⿢ࡵޣܡⷨথ෎䞥ܡ䰸ᅵᡍ䌍⫼ⷨথᯊ䯈ⷁ᳈催ⱘ㥃ᬓ៤ࡳ⥛ᰃϔϾϾϾϾϾϾϾϾϾϾϾৃৃৃৃৃৃৃৃৃৃৃҹҹҹҹ㦋Ӭ࢓ⱘӋḐᬓㄪᬊⲞᖿᅵᡍ䮼ᾯԢ᳈ࡴӬᚴⱘ೑ᆊ㸹䌈᳈䭓ⱘ⣀ऴᳳ0%10%20%30%40%50%2001200220032004200520062007200820092010YoYGrowthRate(%)OrphanDrugs(CAGR;25.8%)Non-orphanControls(CAGR;20.1%)؅ҩ哦࣒١֫ٝ৆ۨО଎ߊӲ哦ٗЏ׍୸ङП੽ݐԈԃ�1983ٶਙя২֢ٝ৆܅ӕд૝ଋ400З؅ҩऒओոդङ哦࣒�NME܅ӕۈރЈ஑�ࣀ৲؅ҩ哦࣒ङ܅ӕչ؅ҩ哦࣒ङܶؔۈރЇԟ�؅ҩ哦࣒١֫ङ׍୸ͧCAGR͹25.8%ͨबثۈѽӲ哦١֫ղ࣫ުੋѩԎSource:ThomsonReutersLifeSciencesConsultingᄸܓ㥃䫔ଂ䍟࢓˄ᣝᑈ䫔ଂⱘ๲䭓˅ᄸܓ㥃⠽ᡍޚ䍟࢓ᴹ⑤˖ThomsonReutersCortellisׂйЇ١ङ؅ҩ哦࣒बثйள؅ҩ哦࣒ङ୦։૟Ԏӣߤުॐӟ؅ҩ哦࣒֨੧ЏИङ୍੽֪ѹ0%10%20%30%40%50%60%70%80%90%100%%ofTotalSalesOrphanDrugs(CAGR:4.2%)Non-orphanDrugs(CAGR:1.1%)᭄᥂ᴹ⑤:ThomsonReuters⫳ੑ⾥ᄺ੼䆶乒䯂ᄸܓ㥃⠽ᇍᘏԧ៬⬹㥃⠽Ꮦഎ䫔ଂⱘ䋵⤂ᣕ㓁๲䭓؅ҩ哦Њள؅ҩ哦ثࡁ05010015020025005101520253035402001200220032004200520062007200820092010Designations(#)Compounds(#)ODAs(CAGR:9.9%)NMEs(CAGR:-1.5%)ODDs(CAGR:10.9%)Source:FDAWebsite؅ҩ哦/ৡ੿ओऀ哦ީ▲ாՕੂӯङ哦࣒ूՇ۫ऋ�؅ҩ哦࣒ङ࣫қٝ৆׍୸ӱЊள؅ҩ哦࣒ঈգङࣙہд�ᄸܓ㥃⠽ⱘᑇഛ⦄ؐ115ғ㕢ܗϢ䴲ᄸܓ㥃⠽ⱘᑇഛ⦄ؐ121ғ㕢䞥↨䕗˄1990ˉ2030˅�؅ҩ哦࣒ङूՇોऀՕਈѫѺ▲п–Лٽؘ௠ओыރ୏੽ࡌص–Лٽؘ௠ޞ୿िͧ3.9v.s.5.4ٶͫиߊЛٽӱЇ١ͨ–ۨԅࣤ௤(93%vs88%)�֜࠴ͫ؅ҩ哦ङӔ࣫қ੽ࡁள؅ҩ哦࣒௤䱣ⴔᯊ䯈ⱘ᥼⿏ˈᄸܓ㥃⠽ⱘӋؐ೼ϡᮁ๲䭓᭄᥂ᴹ⑤:ThomsonReuters⫳ੑ⾥ᄺ੼䆶乒䯂N=23N=80N=50N=257$-$20,000$40,000$60,000$80,000$100,000$120,000$140,000$160,000$180,000$-$100$200$300$400$500$600$70020002010TotalPVofalldrugs($m)MeanPVperdrug($m)MeanorphanMeanNon-orphanOrphanNon-OrphanۨԅࣤЊڐՇޞ୿ङثࡁ؅ҩ哦ङઍચЊфսЇ١ך୍؅ҩ哦૯ѡٶ߂૊ङ哦ș9UROXOY'RK^OUT6NGXSGIK[ZOIGRY–ٶ߂૊ङ哦࣒ͫь২ҫ–࠿ٶङ࡞ऐોऀ;9–࡞ऐȔஈՇۅशलۅ੦঱堢गㆲȕVGXU^_Y_SGRTUIZ[XTGRNKSUMRUHOT[XOG64.–Ҷ২ѳઋ߄Ȍ64.ओы–Џӄङжખ͹ԛऐѽ঩ИީիܴСԝם؅ҩ哦࣒䗮⫼ৡ⊏⭫乚ඳᡬ⦄PV˄कғ˅ᔧ᳔ࠡ催䫔ଂӋؐ˄कғ˅߽ཹᯨऩᡫ㚓⯸$154$7䳋⦴ऩᡫⴐ⾥.$74$5⫳䭓▔㋴(epr)ҷ䇶$62$3ᴹ䙷ᑺ㛎㚓⯸$60$5⬆⻎䝌Ӟ偀᳓ሐ㚓⯸$42$5䴲Ḑৌҁ㸔⎆㋏㒳$42$2䝟䝌Ḑᢝ᳓䳋MSP$40$4䞡㒘಴ᄤVIII˗䕯ޱ㸔㋴㸔⎆㋏㒳$28$1⊶⫳ഺ˄ϔ∈࣪⠽˅ᖗ㸔ㅵ㋏㒳$27$2⹐᳓Ԥ㉇㚓⯸$24$2ٶ5*+ӱߊङ؅ҩ哦࣒2011ᑈ㕢೑䫔ଂ乱˄ⱒϛ˅ᄸܓ㥃⣀ऴᳳ2011ᑈ೼㕢೑ࠄᳳⱘ㥃⠽⌏ᗻ៤ߚ㔩㾕䗖ᑨ⮛$500SensiparⲤ䝌㽓䙷वา⬆⢊ᮕ㝎ࡳ㛑Ѷ䖯$300Vidaza䰓ᠢ㚲㣋偼傧๲⫳ᓖᐌ㓐ড়ᕕ$50-100AcetadoteЭ䝄ञ㛅⇼䝌䝟⇼䜮䖛䞣Clolar∃⊩ᢝⒼᗹᗻ⎟Ꮘ㒚㚲ᗻⱑ㸔⮙$5-15Tindamax᳓⸱૥㒚㦠ᗻ䰈䘧⮙ঞⓈ㰿⮙VentavisӞ⋯ࠡ߫㋴III㑻ॳথᗻ㚎ࡼ㛝催㸔य़NUTRESTORE䈋⇼䝄㛎Ϣ⫳䭓▔㋴ϔ䍋Փ⫼ˈ䗖⫼Ѣܜ໽ᗻⷁ㙴㓐ড়ᕕ$1៪᳈ᇥApokynⲤ䝌䰓ᠥ৫ଵᏩ䞥Ể⮙ঞℸ⮙Ⳍ݇⮙⮛Luveris֗咘ԧ▔㋴֗ᗻ㝎▔㋴ߚ⊠ϡ䎇᠔㟈ᗻ㝎ᴎ㛑ޣ䗔ϡ㚆⮛˄LH㔎У˅ⱘ⫳㚆㥃Membraneblue䫹㰿㪱ⴐ⾥᠟ᴃᯊ㒚㚲㝰ᶧ㡆᠔⫼ᶧ᭭PentateCalciumtrisodiumϝ㛎ѨЭ䝌䩭ϝ䩴⊏⭫ԧݙ䩮ǃ䬙៪䫨∵ᶧPentetateZincTrisodiumϝ㛎ѨЭ䝌䫠ϝ䩴⊏⭫ԧݙ䩮ǃ䬙៪䫨∵ᶧᴹ⑤˖ThomsonReutersNewportPremium,IMSHealthݕসșৡ੿ओऀ哦؅ҩ哦࣒ͧ5XVNGTJX[Mͨङএѐș֢எ࣫ࣙ澝૟Ԏ澝ي߈–؅ҩ哦࣒ङݺঌׂॅ澝ѩۙߚў–ৡ੿ओऀ哦ङ哦࣒৆ࡺ؆ӣߤ